Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
809 people get APPA.OB articles and Market Currents by email alert.
Get email alerts on APPA.OB »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
Business Wire (May 10, 2013)
-
Business Wire (May 2, 2013)
-
Business Wire (Mar 28, 2013)
-
Business Wire (Feb 28, 2013)
-
Insiders Bought These Shares On September 12StockPandit • Thu, Sep 13, 2012
To learn more about Seeking Alpha Pro, click here.
-
Insiders Bought These Shares On September 12StockPandit • Thu, Sep 13, 2012
-
Mannkind Slashes Staff: Biotech's Latest TribulationsThe Burrill Report • Sun, Feb 13, 2011
There are no Transcripts on APPA.OB.
-
Business Wire (May 10, 2013)
-
Business Wire (May 2, 2013)
-
Business Wire (Mar 28, 2013)
-
Business Wire (Feb 28, 2013)
APPA.OB vs. ETF Alternatives
Company Description
Currently, there's no company description for APPA.OB.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Thursday, March 28, 2:12 PM AP Pharma (APPA.OB -32.6%) dives after FDA denies approval for chemotherapy nausea treatment citing issues with AP's syringe administration system and manufacturing facilities. SA contributor Smith on Stocks says the issues are resolvable and, consistent with the company's own projections, sees approval in H1 2014. Comment! [Healthcare]
- Monday, January 14, 2:32 PM Investors interested in the prospects of young biotech companies might want to take a look at this Seeking Alpha article. It's a list of the upcoming FDA approval decision dates for Q1 2013, and with many of these developing firms having a good portion of their businesses riding on FDA approval decisions for their newly developed drugs, the stocks are likely to be sensitive to any positive or negative news over the near term. Comment! [Healthcare, Quick Ideas]
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.





